Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been diagnosed with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS), confirmed through structured assessments
- You are able to read and sign a consent form agreeing to take part
- You are able to commit to taking part for the full length of the study
Who may not be able to join:
- You have a neurological condition such as spinal cord injury, a nervous system disease, brain tumor, or have had a stroke
- You have been diagnosed with a primary psychotic disorder or major thought disorder in the past five years
- You have been hospitalized for psychiatric reasons (other than suicidal thoughts, homicidal thoughts, or PTSD) within the past five years
- You have a psychiatric or behavioral condition that is currently unstable or severe, such as active mania, psychosis, active suicidal thoughts, homicidal thoughts, or substance dependency within the past six months
- You do not speak English
- You are currently experiencing active suicidal thoughts with intent to harm yourself, or active delusional or psychotic thinking
- You have difficulty communicating by telephone or video call
- You have upcoming life events that would prevent you from fully taking part in the study
- You have a significant active medical condition that would prevent participation (confirm with trial site)
- You are currently pregnant
- You are currently being treated for cancer
- Your pain is related to cancer
- You are currently receiving, or have recently received, a similar type of treatment, such as individual talk therapy or pelvic floor physical therapy
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lindsey McKernan, PhD, MPH, Vanderbilt University Medical Center
Phone: 615-875-9990
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Differences in response to treatment by phenotype measured by the Global Response Assessment (GRA) scale.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.